Aytu Biopharma, Inc
AYTUNasdaqCIK 1385818HealthcareFiscal year ends Jun 30
Reports and events: 372 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2216:30 ET | DEF 14A | Proxy statementPeriod 2026-12-10 | 0001437749-26-033276 |
| 2026-09-2216:14 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001437749-26-030908 |
| 2026-09-2216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-030900 |
| 2026-06-2516:31 ET | 8-K | 1.02 Termination of a material agreement | 0001437749-26-021707 |
| 2026-05-1316:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-016721 |
| 2026-05-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016717 |
| 2026-04-0216:08 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001437749-26-011116 |
| 2026-02-0316:08 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001437749-26-002804 |
| 2026-02-0316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-002799 |
| 2026-01-2016:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-001543 |
| 2025-12-1016:05 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-037389 |
| 2025-11-1316:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034825 |
| 2025-11-1316:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034822 |
| 2025-10-2416:02 ET | DEF 14A | Proxy statementPeriod 2025-12-10 | 0001437749-25-031719 |
| 2025-09-2316:06 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001437749-25-029723 |
| 2025-09-2316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-029721 |
| 2025-08-0716:20 ET | 8-K | 1.02 Termination of a material agreement | 0001437749-25-025441 |
| 2025-06-2308:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-020973 |
| 2025-06-1706:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-020579 |
| 2025-06-0916:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-057855 |
| 2025-06-0916:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-019868 |
| 2025-06-0616:07 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-019719 |
| 2025-06-0616:07 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-019718 |
| 2025-06-0516:15 ET | S-1/A | Registration statement, amended | 0001437749-25-019550 |
| 2025-06-0217:16 ET | S-1 | Registration statement | 0001437749-25-019189 |
| 2025-05-2116:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-017989 |
| 2025-05-1416:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-016833 |
| 2025-05-1416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016832 |
| 2025-03-2816:02 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001437749-25-009836 |
| 2025-02-1216:12 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001437749-25-003568 |
| 2025-02-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-003563 |
| 2024-12-0421:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-036630 |
| 2024-11-1317:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034970 |
| 2024-11-1316:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-034898 |
| 2024-10-0108:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-030297 |
| 2024-09-2616:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-030075 |
| 2024-09-2616:05 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001437749-24-030062 |
| 2024-08-0608:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-024725 |
| 2024-06-2616:36 ET | 8-K | 5.07 Shareholder vote results | 0001437749-24-021296 |
| 2024-06-1816:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-072841 |
| 2024-06-1808:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-020590 |
| 2024-05-1516:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-017058 |
| 2024-05-1516:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-017051 |
| 2024-05-1016:06 ET | DEF 14A | Proxy statementPeriod 2024-06-26 | 0001437749-24-016003 |
| 2024-02-1416:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-004155 |
| 2024-02-1416:05 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001437749-24-004149 |
| 2023-11-1716:10 ET | 8-K | 1.01 Entry into a material agreement | 0001558370-23-019194 |
| 2023-11-1416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-019023 |
| 2023-11-1416:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-019015 |
| 2023-10-2608:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-016776 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.